EUR 3.06
(1.32%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 98.69 Million EUR | -19.84% |
2022 | 123.13 Million EUR | 21.27% |
2021 | 101.53 Million EUR | 19.67% |
2020 | 84.84 Million EUR | 3.32% |
2019 | 82.11 Million EUR | 3.28% |
2018 | 79.5 Million EUR | 8.79% |
2017 | 73.08 Million EUR | 2.78% |
2016 | 71.1 Million EUR | -3.58% |
2015 | 73.74 Million EUR | -0.13% |
2014 | 73.83 Million EUR | 5.53% |
2013 | 69.96 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 90.36 Million EUR | -8.45% |
2024 Q2 | 90.36 Million EUR | 0.0% |
2023 FY | 98.69 Million EUR | -19.84% |
2023 Q2 | 107.96 Million EUR | 0.0% |
2023 Q4 | 98.69 Million EUR | 0.0% |
2023 Q1 | 107.96 Million EUR | -12.31% |
2022 Q1 | 120.58 Million EUR | 18.76% |
2022 FY | 123.13 Million EUR | 21.27% |
2022 Q4 | 123.13 Million EUR | -1.75% |
2022 Q3 | 125.32 Million EUR | 3.93% |
2022 Q2 | 120.58 Million EUR | 0.0% |
2021 Q3 | 103.41 Million EUR | 19.58% |
2021 Q1 | 86.48 Million EUR | 1.35% |
2021 Q2 | 86.48 Million EUR | 0.0% |
2021 Q4 | 101.53 Million EUR | -1.82% |
2021 FY | 101.53 Million EUR | 19.67% |
2020 Q4 | 85.33 Million EUR | -1.64% |
2020 Q2 | 80.43 Million EUR | 0.0% |
2020 Q1 | 80.43 Million EUR | -2.05% |
2020 FY | 84.84 Million EUR | 3.32% |
2020 Q3 | 86.75 Million EUR | 7.86% |
2019 Q3 | 83.71 Million EUR | -0.68% |
2019 Q4 | 82.11 Million EUR | -1.92% |
2019 Q2 | 84.29 Million EUR | 0.0% |
2019 FY | 82.11 Million EUR | 3.28% |
2019 Q1 | 84.29 Million EUR | 4.0% |
2018 Q4 | 81.05 Million EUR | 0.0% |
2018 Q3 | 81.05 Million EUR | 14.25% |
2018 Q2 | 70.94 Million EUR | 0.0% |
2018 Q1 | 70.94 Million EUR | -6.99% |
2018 FY | 79.5 Million EUR | 8.79% |
2017 Q4 | 76.28 Million EUR | 0.0% |
2017 FY | 73.08 Million EUR | 2.78% |
2017 Q3 | 76.28 Million EUR | 6.63% |
2017 Q2 | 71.53 Million EUR | 0.0% |
2017 Q1 | 71.53 Million EUR | -4.44% |
2016 Q1 | 53.06 Million EUR | -31.7% |
2016 FY | 71.1 Million EUR | -3.58% |
2016 Q4 | 74.86 Million EUR | 0.0% |
2016 Q3 | 74.86 Million EUR | 41.07% |
2016 Q2 | 53.06 Million EUR | 0.0% |
2015 Q2 | 76.87 Million EUR | 7.63% |
2015 Q4 | 77.69 Million EUR | 0.85% |
2015 FY | 73.74 Million EUR | -0.13% |
2015 Q1 | 71.42 Million EUR | -3.26% |
2015 Q3 | 77.04 Million EUR | 0.22% |
2014 Q1 | 67.39 Million EUR | -3.67% |
2014 Q3 | 70.04 Million EUR | 10.32% |
2014 Q2 | 63.49 Million EUR | -5.79% |
2014 FY | 73.83 Million EUR | 5.53% |
2014 Q4 | 73.83 Million EUR | 5.4% |
2013 FY | 69.96 Million EUR | 0.0% |
2013 Q2 | 79.13 Million EUR | 4.72% |
2013 Q3 | 76.92 Million EUR | -2.8% |
2013 Q4 | 69.96 Million EUR | -9.04% |
2013 Q1 | 75.56 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Evrofarma SA | 31.13 Million EUR | -217.039% |
Flour Mills Kepenos S.A. | 37.23 Million EUR | -165.044% |
Kri-Kri Milk Industry S.A. | 50.89 Million EUR | -93.92% |